Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Raised to $78 at RBC Capital

August 7, 2024 7:00 AM
RBC Capital analyst Shagun Singh raised the price target on Globus Medical (NYSE: GMED) to $78.00 (from $76.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles